GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Clean Science and Technology CLEAN.NS · INR

Materials · NSE · 🇮🇳 India

Compare

695.95

+4.04%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Clean Science and Technology

Its shares trade on NSE under the ticker CLEAN.NS. It has been listed since 19 July 2021. In the fiscal year to 31 March 2026, it reported revenue of ₹9.57bn and net income of ₹2.30bn. At that date it held total assets of ₹17.83bn and shareholders' equity of ₹15.84bn.

Clean Science & Technology Ltd. manufactures chemicals. The company is headquartered in Pune, Maharashtra. The company went IPO on 2021-07-19. The firm is engaged in the business of manufacturing organic and inorganic chemicals. The company operates through the Speciality Chemicals segment. Its specialty chemical chemistry is diversified into three segments, such as FMCG Chemical, Performance Chemicals, and Pharmaceutical Chemicals. Its FMCG chemicals include Anisole, 4-Methoxy Acetophenone, Guaiacol, Butylated Hydroxy Anisole, Tertiary Butyl Hydroquinone, Ortho Methoxy Toluene, and L-Ascorbyl Palmitate, among others. Its performance chemicals include Clean Light Stab 770, 4-Hydroxy Tempo, Monomethyl Ether of Hydroquinone, 2,5-Di-Tertiary Butyl Hydroquinone, Tertiary Butyl Hydroquinone, Dimethyl Sebacate (DMS), and others. Its pharma and agro intermediates include Para Benzoquinone, Para Di-Methoxy Benzene (1,4-DMB), Ortho Methoxy Toluene, and others. The firm caters to both domestic and international markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Materials
Industry
Chemicals
Listed since
19 Jul 2021
Employees
502

Leadership

Pay as last reported

  • Mr. Pradeep RathiNon-Executive Chairman of the Board₹390,000
  • Mr. Sanjay ParnerkarChief Financial Officer₹4.8m
  • Ms. Ruchita VijChief Compliance Officer, Company Secretary
  • Mr. Ashok BoobManaging Director, Executive Director₹94.9m
  • Mr. Krishnakumar BoobWhole-Time Director, since 2021₹57.4m
  • Mr. Siddhartha SikchiWhole-Time Director, since 2021₹85.5m
  • Mr. Sanjay KothariNon-Executive Director₹510,000
  • Mr. Keval DoshiNon-Executive Independent Director₹510,000
  • Ms. Pallavi GokhaleAdditional Non-Executive Independent Director
  • Mr. Raj KamalAdditional Non-Executive Independent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
63
Environment
74
Social
61
Governance
54
Direct emissions (scope 1)
101,491 t
Energy emissions (scope 2)
7,448 t
Value chain emissions (scope 3)
696 t
Women in the workforce
9%
Carbon reduction policy
Yes
Human rights policy
Yes

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Manufactures organic and inorganic chemicals with diversified segments including FMCG, Performance, and Pharma.
  • Operates through Speciality Chemicals segment with key products like Anisole and Clean Light Stab 770.
  • Serves domestic and international markets with 502 employees and IPO listing since 2021.

Weaknesses

  • Headquartered in Pune, Maharashtra, which may limit access to global markets.
  • Relies on specific chemical products like Tertiary Butyl Hydroquinone for revenue.
  • Limited to Materials sector with no diversification into other industries.

Opportunities

  • Expanding into international markets for FMCG Chemicals like L-Ascorbyl Palmitate.
  • Growing demand for Performance Chemicals such as Dimethyl Sebacate (DMS) in global industries.
  • Increasing pharmaceutical chemical needs for products like Para Benzoquinone.

Threats

  • Competition from global chemical manufacturers in the Materials sector.
  • Regulatory changes affecting chemical production in India.
  • Economic downturns impacting demand for specialty chemicals.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.